Vulvar Cancer Latest Advances

Vulvar cancer should prompt screening for anal cancer.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Published: April 13, 2026

Squamous Precursor Lesions of the Vulva: A Practical Approach.

Journal: Dermatologic clinics

Published: April 08, 2026

Common Vulvar Neoplasms-Benign and Malignant.

Journal: Clinical obstetrics and gynecology

Published: March 30, 2026

Cellular angiofibroma of labia minora in pregnancy.

Journal: BMJ case reports

Published: March 23, 2026

Recurrent Papillary Apocrine Carcinoma of the Vulva.

Journal: The American Journal of dermatopathology

Published: March 18, 2026

Significance of positive excision margins in therapy of high-grade vulvar precancerosis - analysis of own data and literary review.

Journal: Ceska gynekologie

Published: March 17, 2026

Diagnostic value of inguinal ultrasound for predicting histological lymph node status in vulvar cancer.

Journal: Ultraschall in der Medizin (Stuttgart, Germany : 1980)

Published: March 09, 2026

Vulvar cancer.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Published: February 23, 2026

Comparison of Indocyanine Green as a Standalone Tracer Versus Technetium-99m Combined with Blue Dye for Sentinel Lymph Node Detection in Vulvar Cancer.

Journal: Journal of minimally invasive gynecology

Published: February 23, 2026

Methodological considerations in assessing the diagnostic accuracy of ultrasound for inguinal lymph nodes in vulvar cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: February 20, 2026

Tisotumab vedotin-associated Stevens-Johnson syndrome in a patient with recurrent vulvar cancer: Vulnerability and antibody drug conjugate toxicity considerations.

Journal: Gynecologic oncology reports

Published: February 13, 2026

EARLY LIFE-COURSE PATTERNS OF REGISTRY-DEFINED SUBSEQUENT CANCERS AFTER HPV-RELATED MALIGNANCIES IN A U.S. POPULATION-BASED COHORT.

Journal: medRxiv : the preprint server for health sciences

Published: February 06, 2026

Vulvar Cancer Latest Advances

Find the Latest Research About Vulvar Cancer

Vulvar cancer should prompt screening for anal cancer.

Vulvar cancer should prompt screening for anal cancer.

Squamous Precursor Lesions of the Vulva: A Practical Approach.

Squamous Precursor Lesions of the Vulva: A Practical Approach.

Common Vulvar Neoplasms-Benign and Malignant.

Common Vulvar Neoplasms-Benign and Malignant.

Cellular angiofibroma of labia minora in pregnancy.

Cellular angiofibroma of labia minora in pregnancy.

Recurrent Papillary Apocrine Carcinoma of the Vulva.

Recurrent Papillary Apocrine Carcinoma of the Vulva.

Significance of positive excision margins in therapy of high-grade vulvar precancerosis - analysis of own data and literary review.

Significance of positive excision margins in therapy of high-grade vulvar precancerosis - analysis of own data and literary review.

Diagnostic value of inguinal ultrasound for predicting histological lymph node status in vulvar cancer.

Diagnostic value of inguinal ultrasound for predicting histological lymph node status in vulvar cancer.

Vulvar cancer.

Vulvar cancer.

Comparison of Indocyanine Green as a Standalone Tracer Versus Technetium-99m Combined with Blue Dye for Sentinel Lymph Node Detection in Vulvar Cancer.

Comparison of Indocyanine Green as a Standalone Tracer Versus Technetium-99m Combined with Blue Dye for Sentinel Lymph Node Detection in Vulvar Cancer.

Methodological considerations in assessing the diagnostic accuracy of ultrasound for inguinal lymph nodes in vulvar cancer.

Methodological considerations in assessing the diagnostic accuracy of ultrasound for inguinal lymph nodes in vulvar cancer.

Tisotumab vedotin-associated Stevens-Johnson syndrome in a patient with recurrent vulvar cancer: Vulnerability and antibody drug conjugate toxicity considerations.

Tisotumab vedotin-associated Stevens-Johnson syndrome in a patient with recurrent vulvar cancer: Vulnerability and antibody drug conjugate toxicity considerations.

EARLY LIFE-COURSE PATTERNS OF REGISTRY-DEFINED SUBSEQUENT CANCERS AFTER HPV-RELATED MALIGNANCIES IN A U.S. POPULATION-BASED COHORT.

EARLY LIFE-COURSE PATTERNS OF REGISTRY-DEFINED SUBSEQUENT CANCERS AFTER HPV-RELATED MALIGNANCIES IN A U.S. POPULATION-BASED COHORT.